🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. quinidine sulfate

    QUINIDINE SULFATE BICYCLE THERAPEUTICS

    ORAL FDA: approved

  2. quinine sulfate

    QUININE SULFATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  3. quizartinib dihydrochloride

    VANFLYTA

    ORAL FDA: approved

  4. quizartinib hydrochloride

    VANFLYTA

    PMDA: approved

  5. rabeprazole sodium

    RABEPRAZOLE SODIUM Amneal Pharma Europe Ltd

    ORAL FDA: approved

  6. radium ra-223 dichloride

    XOFIGO

    INTRAVENOUS FDA: approved

  7. radium ra223 dichloride

    XOFIGO

    EMA: approved

    V10XX03

  8. raloxifene hydrochloride

    RALOXIFENE HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  9. raltegravir potassium

    RALTEGRAVIR VIATRIS

    ORAL FDA: approved · EMA: application withdrawn · PMDA: approved

    J05AJ01

  10. ramipril + felodipine

    TRIASYN 5.0/5.0 Sanofi-aventis Healthcare Pty Ltd

    TGA: approved

  11. ramosetron hydrochloride

    IRRIBOW

    PMDA: approved

  12. ranibizumab-eqrn

    CIMERLI

    INJECTION FDA: approved

  13. ranibizumab-leyk

    NUFYMCO

    FDA: approved

  14. ranibizumab-nuna

    BYOOVIZ

    INJECTION FDA: approved

  15. ranitidine bismuth citrate

    TRITEC

    ORAL FDA: approved

  16. ranitidine hydrochloride

    RANITIDINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  17. rapacuronium bromide

    RAPLON

    INJECTION FDA: approved

  18. rasagiline mesylate

    RASAGILINE MESYLATE Teva Pharma GmbH

    ORAL FDA: approved

  19. rauwolfia serpentina root

    RAUWOLFIA SERPENTINA Teva Pharma GmbH

    ORAL FDA: approved

  20. ravulizumab-cwvz

    ULTOMIRIS

    INJECTION FDA: approved

  21. rc18 160 mg

    NMPA: clinical trials

  22. recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)

    CERVARIX

    PMDA: approved

  23. recombinant coronavirus (sars-cov-2) vaccine

    COVGOZE

    PMDA: approved

  24. recombinant human c1 inhibitor

    RHUCIN

    EMA: refused

    B06C

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources